Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Hao L, Boehnke N, Elledge SK, Harzallah NS, Zhao RT, Cai E, et al. Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system. Proc Natl Acad Sci USA. 2024;121:e2307802121.
Gong L, Li G, Yi X, Han Q, Wu Q, Ying F, et al. Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells. Cell Commun Signal. 2024;22:47.
Giampaolino P, Foreste V, Della Corte L, Di Filippo C, Iorio G, Bifulco G. Role of biomarkers for early detection of ovarian cancer recurrence. Gland Surg. 2020;9:1102–11.
Zou Y, Gao B, Lu J, Zhang K, Zhai M, Yuan Z, et al. Long non-coding RNA CASC15 enhances learning and memory in mice by promoting synaptic plasticity in hippocampal neurons. Exploration. 2024;4:20230154.
Coan M, Haefliger S, Ounzain S, Johnson R. Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. 2024;25:578–95.
Nadhan R, Isidoro C, Song YS, Dhanasekaran DN. LncRNAs and the cancer epigenome: mechanisms and therapeutic potential. Cancer Lett. 2024;605:217297.
Li Y, Li F, Ding M, Ma Z, Li S, Qu J, et al. Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway. Chin Herb Med. 2024;16:82–93.
Tang J, Wang X, Xiao D, Liu S, Tao Y. The chromatin-associated RNAs in gene regulation and cancer. Mol Cancer. 2023;22:27.
Ha JH, Radhakrishnan R, Nadhan R, Gomathinayagam R, Jayaraman M, Yan M, et al. Deciphering a GPCR-lncRNA-miRNA nexus: identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024;591:216891.
Dubiez E, Pellegrini E, Finderup Brask M, Garland W, Foucher AE, Huard K, et al. Structural basis for competitive binding of productive and degradative co-transcriptional effectors to the nuclear cap-binding complex. Cell Rep. 2024;43:113639.
Song Y, Chen C, Li W. Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: a review of therapeutic potentials and molecular mechanisms. Chin Herb Med. 2024;16:489–504.
Zhang R, Yang R, Huang Z, Xu X, Lv S, Guan X, et al. METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression. Heliyon. 2023;9:e22595.
Jiang T, Wang Y, Chen X, Xia W, Xue S, Gu L, et al. Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer. Front Cell Dev Biol. 2023;11:1117637.
Li P, Ma X, Gu X. LncRNA MAFG-AS1 is involved in human cancer progression. Eur J Med Res. 2023;28:497.
Khorkova O, Stahl J, Joji A, Volmar CH, Wahlestedt C. Amplifying gene expression with RNA-targeted therapeutics. Nat Rev Drug Discov. 2023;22:539–61.
Abd-Allah GM, Ismail A, El-Mahdy HA, Elsakka EGE, El-Husseiny AA, Abdelmaksoud NM, et al. miRNAs as potential game-changers in melanoma: a comprehensive review. Pathol Res Pract. 2023;244:154424.
Azizi M, Salehi-Mazandarani S, Nikpour P, Andalib A, Rezaei M. The role of unfolded protein response-associated miRNAs in immunogenic cell death amplification: a literature review and bioinformatics analysis. Life Sci. 2023;314:121341.
Chen Y, Gu M, Liu C, Wan X, Shi Q, Chen Q, et al. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. Gene. 2019;686:37–42.
Xu Y, Yao Y, Gao P, Cui Y. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294. Biochem Biophys Res Commun. 2019;509:138–42.
Huang L, Chen M, Pan J, Yu W. Circular RNA circNASP modulates the malignant behaviors in osteosarcoma via miR-1253/FOXF1 pathway. Biochem Biophys Res Commun. 2018;500:511–7.
Liu M, Zhang Y, Zhang J, Cai H, Zhang C, Yang Z, et al. MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. Cell Death Dis. 2018;9:189.
Wen T, Zhang X, Gao Y, Tian H, Fan L, Yang P. SOX4-BMI1 axis promotes non-small cell lung cancer progression and facilitates angiogenesis by suppressing ZNF24. Cell Death Dis. 2024;15:698.
Zhao S, Li P, Zhou G. Long noncoding RNAs in the prediction of survival of patients with digestive cancers. Turk J Gastroenterol. 2023;34:19–25.
Duan WW, Yang LT, Liu J, Dai ZY, Wang ZY, Zhang H, et al. A TGF-beta signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30:e14489.
Yang D, Zhang D. miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patient prognosis. Clin Exp Med. 2021;21:563–71.
Xiong W, Yang J. CircSEC24A induces KLF8 expression to promote the malignant progression of non-small cell lung cancer by regulating miR-1253. Thorac Cancer. 2024;15:2461–73.
Ding X, Zheng J, Cao M. Circ_0004771 accelerates cell carcinogenic phenotypes via suppressing miR-1253-mediated DDAH1 inhibition in breast cancer. Cancer Manag Res. 2021;13:1–11.
Sheykhi-Sabzehpoush M, Ghasemian M, Khojasteh Pour F, Mighani M, Moghanibashi M, Mohammad Jafari R, et al. Emerging roles of long non-coding RNA FTX in human disorders. Clin Transl Oncol. 2023;25:2812–31.
Pramio D, Schechtman D. Chromatin immunoprecipitation on fixed tissues and cell lines. Methods Mol Biol. 2023;2599:21–31.
Shahid S, Khan A, Shahid W, Rehan M, Asif R, Nisar H, et al. Nanoenzymes: a radiant hope for the early diagnosis and effective treatment of breast and ovarian cancers. Int J Nanomed. 2024;19:5813–35.
Qian L, Chen Y, Peng M, Xia Y, Zhou T, Hong J, et al. The importance of marital status in the morbidity and prognosis of lung metastasis in newly diagnosed ovarian cancer. J Cancer. 2023;14:1024–38.
Drymiotou S, Theodorou E, Rallis KS, Nicolaides M, Sideris M. Molecular biomarkers in borderline ovarian tumors: towards personalized treatment and prognostic assessment. Cancers. 2025;17:545.
Ren Z, Hu Y, Chen J, & Jin L. MicroRNA-200a inhibits TGF-β-induced epithelial-mesenchymal transition in human ovarian carcinoma cells by downregulating SOX4 expression. Arch Med Sci. 2021. https://doi.org/10.5114/aoms/139106.
Xi J, Feng J, Zeng S. Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4. Am J Cancer Res. 2017;7:2180–9.
Yeh YM, Chuang CM, Chao KC, Wang LH. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer. 2013;133:867–78.
Loric S, Denis JA, Desbene C, Sabbah M, Conti M. Extracellular vesicles in breast cancer: from biology and function to clinical diagnosis and therapeutic management. Int J Mol Sci. 2023;24:7208.
Buczyńska A, Sidorkiewicz I, Niemira M, Krętowski AJ, Węgrzyn P, Kosiński P, et al. Identification of MicroRNA profiles in fetal spina bifida: the role in pathomechanism and diagnostic significance. Int J Mol Sci. 2024;25:2896.
Feng D, Li D, Wang J, Wu R, Zhang C. Senescence-associated lncRNAs indicate distinct molecular subtypes associated with prognosis and androgen response in patients with prostate cancer. Acta Mater Med. 2023;2:299–309.
Li J, Li Z, Wang Y, Lin H, Wu B. TLSEA: a tool for lncRNA set enrichment analysis based on multi-source heterogeneous information fusion. Front Genet. 2023;14:1181391.
Liu J, Zhang B, Wang L, Li S, Long Q, Xiao X. Bioactive components, pharmacological properties and underlying mechanism of Ganoderma lucidum spore oil: a review. Chin Herb Med. 2024;16:375–91.
He H, Li T. Hsa_circ_0000190 promotes NSCLC cell resistance to cisplatin via the modulation of the miR-1253/IL-6 Axis. Anal Cell Pathol. 2024;2024:6647810.
Mo J, Zheng T, Lei L, Dai P, Liu J, He H, et al. MicroRNA-1253 suppresses cell proliferation, migration, and invasion of osteosarcoma by targeting MMP9. Technol Cancer Res Treat. 2021;20:1533033821995278.
Crump LS, Wyatt GL, Rutherford TR, Richer JK, Porter WW, Lyons TR. Hormonal regulation of semaphorin 7a in ER(+) breast cancer drives therapeutic resistance. Cancer Res. 2021;81:187–98.
Feng P, Wang Y, Liu N, Chen Y, Hu Y, Huang Z, et al. High expression of PPP1CC promotes NHEJ-mediated DNA repair, leading to radioresistance and poor prognosis in nasopharyngeal carcinoma. Cell Death Differ. 2024;31:683–96.
Zhai Y, Zhang F, Zhou J, et al. Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics. Chin Med. 2024;19:129.
Li Z, Wang F. Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer. Transl Cancer Res. 2023;12:2048–62.
Wu D, He X, Wang W, Hu X, Wang K, Wang M. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Mol Oncol. 2020;14:2332–51.
Liu X, Wang Y, Zhou G, Zhou J, Tian Z, Xu J. circGRAMD1B contributes to migration, invasion and epithelial-mesenchymal transition of lung adenocarcinoma cells via modulating the expression of SOX4. Funct Integr Genom. 2023;23:75.
Wang S, Zhu X, Hao Y, Su TT, Shi W. ALKBH5-mediated m6A modification of circFOXP1 promotes gastric cancer progression by regulating SOX4 expression and sponging miR-338-3p. Commun Biol. 2024;7:565.
Consortium GT. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580–5.
Li J, Ma S, Zheng Y, Qin M, Jia H, Liu C, et al. Prognostic value and immune infiltration analyses of cuproptosis-related genes in hepatocellular carcinoma. Acta Mater Med. 2023;2:386–99.
Zhang X, Wang C, Xu H, Cai S, Liu K, Li S, et al. Propofol inhibits myocardial injury induced by microvesicles derived from hypoxia-reoxygenated endothelial cells via lncCCT4-2/CCT4 signaling. Biol Res. 2023;56:20.
Bai X, Kang J, Wei S, Wang Y, Liu Y, Yuan B, et al. A pH-responsive nanocomposite for combination sonodynamic-immunotherapy with ferroptosis and calcium ion overload via SLC7A11/ACSL4/LPCAT3 pathway. Exploration. 2024;5:20240002.